|Work hours||Add information|
|About||TMII is advancing the science of imaging, from the development of new visualization technology to improved contrast agents and drug delivery|
|Mission||The mission of TMII is to research, develop, and apply a new generation of imaging methodologies in order to advance preclinical and translational research activities. This will result in new methods for drug delivery, as well as in the establishment of new classes of contrast agents which may improve disease detection, disease characterization, clinical diagnosis, treatment and monitoring of therapeutic responses.|
The Translational and Molecular Imaging Institute (TMII) aims to promote an array of next-generation, world-class biomedical imaging resources to be used by clinical and translational researchers of the various institutes at Mount Sinai as well as by our collaborators. TMII provides advanced, highly efficient and cost-effective imaging services, and offers expertise for the development and validation of new procedures, encouraging interdisciplinary collaborations that merge the gap between preclinical and clinical research.
TMII is organized in three different Programs and a Core:
The Cardiovascular Imaging Program is headed by Zahi A. Fayad, Ph.D.
The Neuroimaging Program by Cheuk Y. Tang, Ph.D.
The Nanomedicine Program by Willem J.M. Mulder, Ph.D.
The Cell Tracking Core is directed by Karen Briley-Saebo, Ph.D.